News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Brian G. Barnett

Articles by Brian G. Barnett

TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study

ByPooja Advani, MBBS, MD,Sofia Braga,Adam M. Brufsky, MD, PhD,Karthik V. Giridhar,Erica L. Mayer, MD, MPH,Kelly E. McCann,Ruth M. O’Regan,Cristina Saura,Seth A. Wander,Georg F. Bischof,Beth H. Lowenthal,Judith D. Bebchuk,Lisa D. Eli,Brian G. Barnett,Joyce A. O’Shaughnessy,Tufia C. Haddad

April 11th 2025

Latest Updated Articles

Trending on CancerNetwork

How Supportive Care Methods Can Improve Oncology Outcomes

FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas

AQUILA Shows “Striking” Benefits With Daratumumab in Smoldering Myeloma

Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma

The Show and After Show: What's Happening at the 43rd Annual Chemotherapy Foundation Symposium?

© 2025 MJH Life Sciences^®

All rights reserved.